(Q33803330)

29 July 2017

title

A novel single-chain-Fv antibody against connective tissue growth factor attenuates bleomycin-induced pulmonary fibrosis in mice (English)

1 reference

29 July 2017

1 reference

Xihua Wang

1

1 reference

29 July 2017

Guoqiu Wu

2

1 reference

29 July 2017

Lixia Gou

3

1 reference

29 July 2017

Zhaozhao Liu

4

1 reference

29 July 2017

Xiyong Wang

5

1 reference

29 July 2017

Xiaobo Fan

6

1 reference

29 July 2017

Linyuan Wu

7

1 reference

29 July 2017

Naifeng Liu

8

1 reference

29 July 2017

publication date

1 April 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

16

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

500-507

1 reference

Non-invasive biomarkers in pulmonary fibrosis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

CCN proteins: multifunctional signalling regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

All in the CCN family: essential matricellular signaling modulators emerge from the bunker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Applications of single-chain variable fragment antibodies in therapeutics and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Bioscreening of phage display antibody library and expression of a humanized single-chain variable fragment antibody against human connective tissue growth factor (CTGF/CCN2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

TGF-beta is a critical mediator of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

High-resolution computed tomography findings of lung cancer associated with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Lung cancer in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Connective tissue growth factor: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Myofibroblasts: molecular crossdressers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Biochemical and structural alterations of hamster lungs in response to intratracheal administration of bleomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Tissue destruction by neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01938.X

10.1111/J.1440-1843.2011.01938.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference